Find Frovatriptan Succinate Hydrate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

160RELATED EXCIPIENT COMPANIES

238EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

API REF. PRICE (USD/KG)

$
$ 0

GLOBAL SALES INFORMATION

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

API

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 158930-17-7, Frovatriptan succinate hydrate, Frovatriptan succinate monohydrate, Frovatriptan succinate [usan], Frovelan, Migard
Molecular Formula
C18H25N3O6
Molecular Weight
379.4  g/mol
InChI Key
CUETXFMONOSVJA-KLQYNRQASA-N
FDA UNII
D28J6W18HY

Frovatriptan Succinate Hydrate
Frovatriptan Succinate is the succinate salt form of frovatriptan, a synthetic triptan with serotonin (5-HT) receptor agonist activity. Frovatriptan succinate binds selectively and with high affinity to 5-HT 1B and presynaptic 5-HT 1D receptors in the extracerebral and intracranial arteries. This leads to an inhibition of serotonin activity and results in vasoconstriction of the painfully dilated blood vessels during migraine attack. Frovatriptan succinate is indicated for the acute treatment of migraine. (NCI05)
1 2D Structure

Frovatriptan Succinate Hydrate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
butanedioic acid;(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide;hydrate
2.1.2 InChI
InChI=1S/C14H17N3O.C4H6O4.H2O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13;5-3(6)1-2-4(7)8;/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18);1-2H2,(H,5,6)(H,7,8);1H2/t9-;;/m1../s1
2.1.3 InChI Key
CUETXFMONOSVJA-KLQYNRQASA-N
2.1.4 Canonical SMILES
CNC1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N.C(CC(=O)O)C(=O)O.O
2.1.5 Isomeric SMILES
CN[C@@H]1CCC2=C(C1)C3=C(N2)C=CC(=C3)C(=O)N.C(CC(=O)O)C(=O)O.O
2.2 Other Identifiers
2.2.1 UNII
D28J6W18HY
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (+)-(r)-5,6,7,8-tetrahydro-6-(methylamino)carbazole-3-carboxamide Succinate (1:1), Monohydrate

2. 3-methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole

3. Allegro

4. Frova

5. Frovatriptan

6. Frovelan

7. Sb 209509

8. Vml-251

9. Vml251

2.3.2 Depositor-Supplied Synonyms

1. 158930-17-7

2. Frovatriptan Succinate Hydrate

3. Frovatriptan Succinate Monohydrate

4. Frovatriptan Succinate [usan]

5. Frovelan

6. Migard

7. Vml 251

8. Sb 209509-ax

9. D28j6w18hy

10. Sb 209509 Ax

11. Nsc-760422

12. Ncgc00183880-01

13. Butanedioic Acid;(6r)-6-(methylamino)-6,7,8,9-tetrahydro-5h-carbazole-3-carboxamide;hydrate

14. (+)-(r)-2,3,4,9-tetrahydro-3-(methylamino)-1h-carbazole-6-carboxamide Butanedioate (1:1), Monohydrate

15. (+)-(r)-5,6,7,8-tetrahydro-6-(methylamino)carbazole-3-carboxamide Succinate (1:1), Monohydrate

16. Butanedioic Acid, Compd. With (r)-2,3,4,9-tetrahydro-3-(methylamino)-1h-carbazole-6-carboxamide (1:1), Monohydrate

17. Butanedioic Acid, Compd. With (r)-2,3,4,9-tetrahydro-3-(methylamino)-1h-carbazole-6-carboxamide, Hydrate (1:1:1)

18. Frovatriptan Succinate (usan)

19. Frovatriptan (succinate Hydrate)

20. (r)-3-(methylamino)-2,3,4,9-tetrahydro-1h-carbazole-6-carboxamide Succinate Hydrate

21. Butanedioic Acid,(6r)-6-methylamino-6,7,8,9-tetrahydro-5h-carbazole-3-carboxamide;hydrate

22. Unii-d28j6w18hy

23. Frova (tn)

24. Dsstox_cid_28982

25. Dsstox_rid_83247

26. Dsstox_gsid_49056

27. Schembl2321442

28. Chembl2138684

29. Dtxsid2049056

30. Hy-b1658a

31. Tox21_113606

32. Akos030241886

33. Frovatriptan Succinate [mart.]

34. Frovatriptan Succinate [usp-rs]

35. Nsc 760422

36. 1h-carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (r)-, Butanedioate (1:1), Monohydrate

37. Frovatriptan Succinate [orange Book]

38. Cas-158930-17-7

39. Cs-0021309

40. D04264

41. Frovatriptan Succinate Monohydrate [mi]

42. Frovatriptan Succinate Monohydrate [who-dd]

43. Frovatriptan Succinate Monohydrate, >=97% (hplc)

44. J-009548

45. Q27276007

46. Frovatriptan Succinate, United States Pharmacopeia (usp) Reference Standard

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 379.4 g/mol
Molecular Formula C18H25N3O6
Hydrogen Bond Donor Count6
Hydrogen Bond Acceptor Count7
Rotatable Bond Count5
Exact Mass379.17433553 g/mol
Monoisotopic Mass379.17433553 g/mol
Topological Polar Surface Area147 Ų
Heavy Atom Count27
Formal Charge0
Complexity426
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Serotonin Receptor Agonists

Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)


API SUPPLIERS

read-more
read-more

01

Biophore India Pharmaceuticals Pvt...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content
USDMF arrow-down Click Us! arrow-down
CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Biophore

02

Viatris

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIOHK2025
Not Confirmed
arrow

Viatris

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BIOHK2025
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

03

Alivus Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIOHK2025
Not Confirmed
arrow

Alivus Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BIOHK2025
Not Confirmed
USDMF arrow-down CEP/COS JDMF EU-WCInactive-api NDC arrow-down KDMF arrow-down VMF Others AUDIT
blank

04

Alivus Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIOHK2025
Not Confirmed
arrow

Alivus Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BIOHK2025
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank

05

Viyash Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIOHK2025
Not Confirmed
arrow

Viyash Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BIOHK2025
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC arrow-down KDMF VMF Others AUDIT
blank

06

Sionc Pharmaceuticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIOHK2025
Not Confirmed
arrow

Sionc Pharmaceuticals

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BIOHK2025
Not Confirmed
USDMF CEP/COS JDMF EU-WCarrow-down NDC arrow-down KDMF VMF Others AUDIT
blank

07

Nosch Labs Pvt

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIOHK2025
Not Confirmed
arrow

Nosch Labs Pvt

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BIOHK2025
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank

08

Dishman Carbogen Amcis

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIOHK2025
Not Confirmed
arrow

Dishman Carbogen Amcis

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BIOHK2025
Not Confirmed
USDMF CEP/COS JDMF EU-WCInactive-api NDC KDMF VMF Others AUDIT
blank

09

Alivus Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

BIOHK2025
Not Confirmed
arrow

Alivus Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
BIOHK2025
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF arrow-down VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

read-more
read-moreread-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothBiophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Flag India
Digital Content Digital Content

GDUFA

DMF Review : Complete

Rev. Date : 2014-03-19

Pay. Date : 2013-09-25

DMF Number : 27284

Submission : 2013-07-16

Status : Active

Type : II

Biophore

02

BIOHK2025
Not Confirmed

02

BIOHK2025
Not Confirmed

GDUFA

DMF Review : Complete

Rev. Date : 2017-03-28

Pay. Date : 2017-03-20

DMF Number : 22952

Submission : 2009-07-17

Status : Active

Type : II

blank

03

BIOHK2025
Not Confirmed
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

read-more
read-moreread-more

01

ECRM CMO & Packaging
Not Confirmed
arrow
arrow
ECRM CMO & Packaging
Not Confirmed

Frovatriptan Succinate IH

Date of Issue : 2022-07-06

Valid Till : 2025-06-25

Written Confirmation Number : WC-0057n

Address of the Firm : Plot No. 3109, GIDC, Industrial Estate Ankleshwar, Distt- Bharuch - 393002, Guja...

blank

02

ECRM CMO & Packaging
Not Confirmed
arrow
arrow
ECRM CMO & Packaging
Not Confirmed

Frovatriptan Succinate IH

Date of Issue : 2022-09-30

Valid Till : 2025-06-30

Written Confirmation Number : WC-0135

Address of the Firm : Survey No.47,48 Paiki sub Plot No.1, Village Lodariyal, Tal -Sanand, Dist -Ahmed...

blank

03

ECRM CMO & Packaging
Not Confirmed
arrow
arrow
ECRM CMO & Packaging
Not Confirmed

Frovatriptan Succinate IH

Date of Issue : 2023-11-15

Valid Till : 2026-05-11

Written Confirmation Number : WC-0273

Address of the Firm : Plot No: 34A, Road No: 1, Jawaharlal Nehru Pharma City, Thanam Village, Parawada...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

read-more
read-moreread-more

01

BIOHK2025
Not Confirmed
arrow
arrow
BIOHK2025
Not Confirmed

Provatriptan succinate monohydrate

Registrant Name : SK Chemical Co., Ltd.

Registration Date : 2023-05-19

Registration Number : No. 69-15-ND(1)

Manufacturer Name : Glenmark Life Sciences Limit...

Manufacturer Address : Plot No 3109, GIDC Industrial Estate, Ankleshwar, District Bharuch, Gujarat - 393 002...

blank

02

BIOHK2025
Not Confirmed
arrow
arrow
BIOHK2025
Not Confirmed

Provatriptan succinate monohydrate

Registrant Name : Bansen Co., Ltd.

Registration Date : 2023-11-30

Registration Number : No. 69-15-ND(A)

Manufacturer Name : Glenmark Life Sciences Limit...

Manufacturer Address : Plot No 3109, GIDC Industrial Estate, Ankleshwar - 393 002, Dist. Bharuch, Gujarat St...

blank

03

BIOHK2025
Not Confirmed
arrow
arrow
BIOHK2025
Not Confirmed

Provatriptan succinate monohydrate

Registrant Name : Iksoo Pharmaceutical Co., Ltd.

Registration Date : 2023-01-10

Registration Number : Su69-15-ND

Manufacturer Name : Glenmark Life Sciences Limit...

Manufacturer Address : Plot No 3109, GIDC Industrial Estate, Ankleshwar, District Bharuch, Gujarat - 393 002...

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

read-more
read-moreread-more

01

BIOHK2025
Not Confirmed
arrow
arrow
BIOHK2025
Not Confirmed

FROVATRIPTAN SUCCINATE

NDC Package Code : 66039-865

Start Marketing Date : 2009-07-17

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

02

BIOHK2025
Not Confirmed
arrow
arrow
BIOHK2025
Not Confirmed

FROVATRIPTAN SUCCINATE

NDC Package Code : 76055-0008

Start Marketing Date : 2019-12-31

End Marketing Date : 2025-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

03

BIOHK2025
Not Confirmed
arrow
arrow
BIOHK2025
Not Confirmed

FROVATRIPTAN SUCCINATE

NDC Package Code : 65015-780

Start Marketing Date : 2015-02-19

End Marketing Date : 2026-12-01

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank

04

BIOHK2025
Not Confirmed
arrow
arrow
BIOHK2025
Not Confirmed

FROVATRIPTAN SUCCINATE

NDC Package Code : 82245-0110

Start Marketing Date : 2001-11-08

End Marketing Date : 2026-12-31

Dosage Form (Strength) : POWDER (1kg/kg)

Marketing Category : BULK INGREDIENT

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

BIOHK2025
Not Confirmed
arrow
arrow
BIOHK2025
Not Confirmed

Frovatriptan Succinate Hydrate

About the Company : Nosch Labs Pvt. Ltd. is a leading pharmaceutical company specializing in the development, manufacturing, and commercialization of high-quality Active Pharmaceutical Ingredients (AP...

Nosch Labs Pvt. Ltd. is a leading pharmaceutical company specializing in the development, manufacturing, and commercialization of high-quality Active Pharmaceutical Ingredients (APIs) and intermediates. With a strong focus on innovation and cutting-edge technology, Nosch Labs delivers a broad range of products that meet international quality standards. The company is dedicated to addressing the global healthcare market's needs by offering reliable, safe, and effective pharmaceutical solutions.
blank

02

BIOHK2025
Not Confirmed
arrow
arrow
BIOHK2025
Not Confirmed

Frovatriptan Succinate Hydrate

About the Company : Sionc pharmaceuticals is specialized in manufacturing of complex and niche Active Pharmaceutical Ingredients in various therapeutic categories. Sionc has evolved as a reliable cont...

Sionc pharmaceuticals is specialized in manufacturing of complex and niche Active Pharmaceutical Ingredients in various therapeutic categories. Sionc has evolved as a reliable contributor in the generic drug industry for Regulatory markets with customer-centric approach since its inception in 2010. To Emerge as a Leading Global Pharmaceutical Company which creates value for all customers by offering excellence in product Quality Standard with committed service and be a significant contributor for global markets.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

BIOHK2025
Not Confirmed
arrow
arrow
BIOHK2025
Not Confirmed

FROVATRIPTAN SUCCINATE

Brand Name : FROVATRIPTAN SUCCINATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Packaging :

Approval Date : 2018-11-06

Application Number : 211292

Regulatory Info : RX

Registration Country : USA

blank

02

BIOHK2025
Not Confirmed
arrow
arrow
BIOHK2025
Not Confirmed

FROVATRIPTAN SUCCINATE

Brand Name : FROVA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Packaging :

Approval Date : 2001-11-08

Application Number : 21006

Regulatory Info : RX

Registration Country : USA

blank

03

BIOHK2025
Not Confirmed
arrow
arrow
BIOHK2025
Not Confirmed

FROVATRIPTAN SUCCINATE

Brand Name : FROVATRIPTAN SUCCINATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Packaging :

Approval Date : 2016-03-11

Application Number : 204730

Regulatory Info : RX

Registration Country : USA

blank

04

BIOHK2025
Not Confirmed
arrow
arrow
BIOHK2025
Not Confirmed

FROVATRIPTAN SUCCINATE

Brand Name : FROVATRIPTAN SUCCINATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Packaging :

Approval Date : 2025-04-16

Application Number : 216998

Regulatory Info : RX

Registration Country : USA

blank

05

Menarini

Italy
BIOHK2025
Not Confirmed
arrow

Menarini

Italy
arrow
BIOHK2025
Not Confirmed

frovatriptansuccinatmonohydrat

Brand Name : Migard

Dosage Form : FILMDRAGERAD TABLETT

Dosage Strength : 2,5 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank

06

BIOHK2025
Not Confirmed
arrow
arrow
BIOHK2025
Not Confirmed

FROVATRIPTAN (FROVATRIPTAN SUCCINATE)

Brand Name : MINT-FROVATRIPTAN

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging :

Approval Date :

Application Number : 2509687

Regulatory Info :

Registration Country : Canada

blank

07

Renata Limited

Bangladesh
BIOHK2025
Not Confirmed
arrow

Renata Limited

Bangladesh
arrow
BIOHK2025
Not Confirmed

FROVATRIPTAN SUCCINATE

Brand Name : FROVATRIPTAN SUCCINATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Packaging :

Approval Date : 2022-04-06

Application Number : 213891

Regulatory Info : RX

Registration Country : USA

blank

08

BIOHK2025
Not Confirmed
arrow
arrow
BIOHK2025
Not Confirmed

FROVATRIPTAN (FROVATRIPTAN SUCCINATE)

Brand Name : FROVATRIPTAN

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging :

Approval Date :

Application Number : 2535475

Regulatory Info :

Registration Country : Canada

blank

09

Country
BIOHK2025
Not Confirmed
arrow

Country
arrow
BIOHK2025
Not Confirmed

FROVATRIPTAN SUCCINATE

Brand Name : FROVATRIPTAN SUCCINATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Packaging :

Approval Date : 2014-08-28

Application Number : 202931

Regulatory Info : DISCN

Registration Country : USA

blank

10

Country
BIOHK2025
Not Confirmed
arrow

Country
arrow
BIOHK2025
Not Confirmed

FROVATRIPTAN (FROVATRIPTAN SUCCINATE)

Brand Name : FROVA

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging : 04-Jul

Approval Date :

Application Number : 2257084

Regulatory Info :

Registration Country : Canada

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

read-more
read-more

01

ECRM CMO & Packaging
Not Confirmed
arrow
arrow
ECRM CMO & Packaging
Not Confirmed

FROVATRIPTAN SUCCINATE

Brand Name : FROVATRIPTAN SUCCINATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Approval Date : 2018-11-06

Application Number : 211292

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

02

ENDO OPERATIONS

Ireland
ECRM CMO & Packaging
Not Confirmed
arrow

ENDO OPERATIONS

Ireland
arrow
ECRM CMO & Packaging
Not Confirmed

FROVATRIPTAN SUCCINATE

Brand Name : FROVA

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Approval Date : 2001-11-08

Application Number : 21006

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

03

ECRM CMO & Packaging
Not Confirmed
arrow
arrow
ECRM CMO & Packaging
Not Confirmed

FROVATRIPTAN SUCCINATE

Brand Name : FROVATRIPTAN SUCCINATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Approval Date : 2016-03-11

Application Number : 204730

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

04

LEADING

U.S.A
ECRM CMO & Packaging
Not Confirmed
arrow

LEADING

U.S.A
arrow
ECRM CMO & Packaging
Not Confirmed

FROVATRIPTAN SUCCINATE

Brand Name : FROVATRIPTAN SUCCINATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Approval Date : 2025-04-16

Application Number : 216998

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

05

RENATA

Bangladesh
ECRM CMO & Packaging
Not Confirmed
arrow

RENATA

Bangladesh
arrow
ECRM CMO & Packaging
Not Confirmed

FROVATRIPTAN SUCCINATE

Brand Name : FROVATRIPTAN SUCCINATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Approval Date : 2022-04-06

Application Number : 213891

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

06

PHARMOBEDIENT

Country
ECRM CMO & Packaging
Not Confirmed
arrow

PHARMOBEDIENT

Country
arrow
ECRM CMO & Packaging
Not Confirmed

FROVATRIPTAN SUCCINATE

Brand Name : FROVATRIPTAN SUCCINATE

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 2.5MG BASE

Approval Date : 2014-08-28

Application Number : 202931

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

BIOHK2025
Not Confirmed
arrow
arrow
BIOHK2025
Not Confirmed

frovatriptansuccinatmonohydrat

Brand Name : Migard

Dosage Form : FILMDRAGERAD TABLETT

Dosage Strength : 2,5 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

read-more
read-more

01

BIOHK2025
Not Confirmed
arrow
arrow
BIOHK2025
Not Confirmed

FROVATRIPTAN (FROVATRIPTAN SUCCINATE)

Brand Name : MINT-FROVATRIPTAN

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging :

Approval Date :

Application Number : 2509687

Regulatory Info :

Registration Country : Canada

blank

02

BIOHK2025
Not Confirmed
arrow
arrow
BIOHK2025
Not Confirmed

FROVATRIPTAN (FROVATRIPTAN SUCCINATE)

Brand Name : FROVATRIPTAN

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging :

Approval Date :

Application Number : 2535475

Regulatory Info :

Registration Country : Canada

blank

03

ENDO OPERATIONS LTD.

Country
BIOHK2025
Not Confirmed
arrow

ENDO OPERATIONS LTD.

Country
arrow
BIOHK2025
Not Confirmed

FROVATRIPTAN (FROVATRIPTAN SUCCINATE)

Brand Name : FROVA

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging : 04-Jul

Approval Date :

Application Number : 2257084

Regulatory Info :

Registration Country : Canada

blank

04

ENDO OPERATIONS LTD.

Country
BIOHK2025
Not Confirmed
arrow

ENDO OPERATIONS LTD.

Country
arrow
BIOHK2025
Not Confirmed

FROVATRIPTAN (FROVATRIPTAN SUCCINATE)

Brand Name : TEVA-FROVATRIPTAN

Dosage Form : TABLET

Dosage Strength : 2.5MG

Packaging : 7

Approval Date :

Application Number : 2415844

Regulatory Info :

Registration Country : Canada

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Coating Systems & Additives

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Granulation

read-more
read-more

Controlled & Modified Release

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Lubricants & Glidants

read-more
read-more

Co-Processed Excipients

read-more
read-more

Topical

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Empty Capsules

read-more
read-more

Solubilizers

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Vegetarian Capsules

read-more
read-more

API Stability Enhancers

read-more
read-more

Taste Masking

read-more
read-more

Coloring Agents

read-more
read-more

Emulsifying Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Parenteral

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 158930-17-7 / Frovatriptan Succinate Hydrate API manufacturers, exporters & distributors?

Frovatriptan Succinate Hydrate manufacturers, exporters & distributors 1

90

PharmaCompass offers a list of Frovatriptan Succinate Hydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Frovatriptan Succinate Hydrate manufacturer or Frovatriptan Succinate Hydrate supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Frovatriptan Succinate Hydrate manufacturer or Frovatriptan Succinate Hydrate supplier.

PharmaCompass also assists you with knowing the Frovatriptan Succinate Hydrate API Price utilized in the formulation of products. Frovatriptan Succinate Hydrate API Price is not always fixed or binding as the Frovatriptan Succinate Hydrate Price is obtained through a variety of data sources. The Frovatriptan Succinate Hydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Frovatriptan Succinate Hydrate

Synonyms

158930-17-7, Frovatriptan succinate monohydrate, Frovatriptan succinate [usan], Frovelan, Migard, Vml 251

Cas Number

158930-17-7

Unique Ingredient Identifier (UNII)

D28J6W18HY

About Frovatriptan Succinate Hydrate

Frovatriptan Succinate is the succinate salt form of frovatriptan, a synthetic triptan with serotonin (5-HT) receptor agonist activity. Frovatriptan succinate binds selectively and with high affinity to 5-HT 1B and presynaptic 5-HT 1D receptors in the extracerebral and intracranial arteries. This leads to an inhibition of serotonin activity and results in vasoconstriction of the painfully dilated blood vessels during migraine attack. Frovatriptan succinate is indicated for the acute treatment of migraine. (NCI05)

DSSTox_CID_28982 Manufacturers

A DSSTox_CID_28982 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_28982, including repackagers and relabelers. The FDA regulates DSSTox_CID_28982 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_28982 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of DSSTox_CID_28982 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

DSSTox_CID_28982 Suppliers

A DSSTox_CID_28982 supplier is an individual or a company that provides DSSTox_CID_28982 active pharmaceutical ingredient (API) or DSSTox_CID_28982 finished formulations upon request. The DSSTox_CID_28982 suppliers may include DSSTox_CID_28982 API manufacturers, exporters, distributors and traders.

click here to find a list of DSSTox_CID_28982 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

DSSTox_CID_28982 USDMF

A DSSTox_CID_28982 DMF (Drug Master File) is a document detailing the whole manufacturing process of DSSTox_CID_28982 active pharmaceutical ingredient (API) in detail. Different forms of DSSTox_CID_28982 DMFs exist exist since differing nations have different regulations, such as DSSTox_CID_28982 USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A DSSTox_CID_28982 DMF submitted to regulatory agencies in the US is known as a USDMF. DSSTox_CID_28982 USDMF includes data on DSSTox_CID_28982's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DSSTox_CID_28982 USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of DSSTox_CID_28982 suppliers with USDMF on PharmaCompass.

DSSTox_CID_28982 KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a DSSTox_CID_28982 Drug Master File in Korea (DSSTox_CID_28982 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of DSSTox_CID_28982. The MFDS reviews the DSSTox_CID_28982 KDMF as part of the drug registration process and uses the information provided in the DSSTox_CID_28982 KDMF to evaluate the safety and efficacy of the drug.

After submitting a DSSTox_CID_28982 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their DSSTox_CID_28982 API can apply through the Korea Drug Master File (KDMF).

click here to find a list of DSSTox_CID_28982 suppliers with KDMF on PharmaCompass.

DSSTox_CID_28982 WC

A DSSTox_CID_28982 written confirmation (DSSTox_CID_28982 WC) is an official document issued by a regulatory agency to a DSSTox_CID_28982 manufacturer, verifying that the manufacturing facility of a DSSTox_CID_28982 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting DSSTox_CID_28982 APIs or DSSTox_CID_28982 finished pharmaceutical products to another nation, regulatory agencies frequently require a DSSTox_CID_28982 WC (written confirmation) as part of the regulatory process.

click here to find a list of DSSTox_CID_28982 suppliers with Written Confirmation (WC) on PharmaCompass.

DSSTox_CID_28982 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing DSSTox_CID_28982 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for DSSTox_CID_28982 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture DSSTox_CID_28982 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain DSSTox_CID_28982 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a DSSTox_CID_28982 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of DSSTox_CID_28982 suppliers with NDC on PharmaCompass.

DSSTox_CID_28982 GMP

DSSTox_CID_28982 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of DSSTox_CID_28982 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_CID_28982 GMP manufacturer or DSSTox_CID_28982 GMP API supplier for your needs.

DSSTox_CID_28982 CoA

A DSSTox_CID_28982 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_28982's compliance with DSSTox_CID_28982 specifications and serves as a tool for batch-level quality control.

DSSTox_CID_28982 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_28982 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

DSSTox_CID_28982 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_28982 EP), DSSTox_CID_28982 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_28982 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty